Solutions for Life Science & Diagnostics
Anti-SLC9A6/NHE6 polyclonal antibody Trial size
Additional Information
Anti-SLC9A6/NHE6 polyclonal antibody Trial size Specifications
| Background: | SLC9A6, also known as NHE6, is a monovalent sodium-selective sodium/hydrogen exchanger (NHE) that is located on the membranes of intracellular organelles such as mitochondria and endosomes. NHEs are involved in a wide array of essential cellular processes, including control of cellular volume and intracellular pH, and reabsorption of sodium across the renal, intestinal, and other epithelia. The dysfunction of SLC9A6 by gene mutations results in an X-linked mental retardation syndrome that is characterized by microcephaly, epilepsy, ataxia, and absent speech and resembles Angelman syndrome. |
| Clonality: | Polyclonal |
| Gene ID Human: | 10479 |
| Gene ID Mouse: | 236794 |
| Host Species: | Rabbit |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Isotype: | IgG |
| Product Type: | Primary Antibody |
| Shipping: | 4 |
| Size: | 10μL |
| Status: | RUO |
| Storage: | -20 |
| Target: | SLC9A6/NHE6 |
Applications:
There are no additional documents for Anti-SLC9A6/NHE6 polyclonal antibody Trial size at this time.
There are no references for Anti-SLC9A6/NHE6 polyclonal antibody Trial size at this time.
